Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
02279 YONGHE MEDICAL
RT Nominal down0.920 -0.030 (-3.158%)
Latest  |  Final  |  Interim
Non-current Assets
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others395,385-36.079%618,551642,296450,213309,437
Land & other Lease Assets541,150-37.926%871,789989,235925,142810,653
Intangible Assets25,850-26.485%35,16339,67841,2573,547
Interests in Asso. & JCEs0--0000
Other Non-current Assets133,98022.097%109,73269,68134,05233,107

1,096,365-32.954%1,635,2351,740,8901,450,6641,156,744
Current Assets
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories40,534-46.669%76,00588,08953,13826,996
Trade Receivables4,632-54.885%10,2677,05513,35110,330
Cash & Bank Balances487,842-19.126%603,215565,0931,566,192292,856
Other Current Assets96,807-19.219%119,839529,241115,958107,430
Assets Held for Sale0--0000

629,815-22.180%809,3261,189,4781,748,639437,612
Current Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables44,884-43.482%79,41643,96836,05944,676
S-T Debt & Leases200,602-37.867%322,860190,554259,228172,921
Other Current Liabilities300,226-6.362%320,625263,986442,393287,603
Liab asso w/ Assets Held for Sale0--0000

545,712-24.511%722,901498,508737,680505,200
Net Current Assets84,103-2.687%86,425690,9701,010,959(67,588)
Total Assets Less Current Liabilities1,180,468-31.434%1,721,6602,431,8602,461,6231,089,156
Non-current Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases466,531-39.623%772,693845,048762,303682,879
Other Non-current Liabilities132-98.035%6,7161,502975219

466,663-40.126%779,409846,550763,278683,098
Capital and Reserves
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital80.000%8880
  Reserves714,329-24.213%942,5491,585,3021,698,337406,058
  Others0--0000
Shareholders' Funds714,337-24.213%942,5571,585,3101,698,345406,058
Non-controlling Interests(532)73.856%(306)000
Others0--0000

713,805-24.245%942,2511,585,3101,698,345406,058
Commitments and Contingent Liabilities
2024/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----9,25238,05579,36277,232
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 17/04/2025 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (K¥)RMB -226,343
%Change-58.575%
EPS / (LPS)RMB -0.450
NBV Per Share (¥)RMB 1.360
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2025 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.